Related Experiment Video
Updated: Dec 29, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
miR-652 protects rats from cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2
Mei-Ling Zuo1, Ai-Ping Wang2, Gui-Lin Song3
1Office of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, 410006, Hunan, China.
Abstract:
Ischemic stroke is a devastating central nervous disease associated with oxidative stress and NOX2 is the main source of ROS responsible for brain tissue. miRNAs are a class of negative regulator of genes in mammals and involves the pathogenesis of ischemic stroke. This study aims to observe the role of target miRNA(miR-652) of NOX2 in ischemic stroke. A rat cerebral ischemia/reperfusion (CI/R) injury model and an SH-SY5Y cell hypoxia/reoxygenation(H/R) model were used to simulate ischemic stroke, and corresponding gene expression, biochemical indicators and pathophysiological indicators were measured to observe the role of miR-652. NOX2 significantly increased in brain tissues subjected to I/R or in SH-SY5Y cells subjected to H/R, while the expression level of miR-652(potential target of NOX2) significantly decreased in both brain tissues and plasma. Overexpression of miR-652 significantly suppressed NOX2 expression and ROS generation in H/R treated SH-SY5Y cells and reduced the relative luciferase activity of cells transfected with plasmid NOX2-WT (reporter gene plasmid). MiR-652 agomir significantly decreased the expression of NOX2 and ROS generation in brain tissues of CIR rats, as well as tissue injury. These data indicated that miR-652 protected rats from cerebral ischemia reperfusion injury by directly targeting NOX2, is a novel target for ischemic stroke therapy.
Insights
MicroRNA-652 (miR-652) protects against ischemic stroke by targeting NOX2, reducing oxidative stress and brain tissue damage. This finding offers a new therapeutic target for stroke treatment.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Ischemic stroke is a major cause of central nervous system damage, linked to oxidative stress.
- NADPH oxidase 2 (NOX2) is a primary source of reactive oxygen species (ROS) implicated in brain injury.
- MicroRNAs (miRNAs) regulate gene expression and play a role in ischemic stroke pathogenesis.
Purpose of the Study:
- To investigate the role of microRNA-652 (miR-652), a potential target of NOX2, in ischemic stroke.
- To elucidate the therapeutic potential of targeting miR-652 in cerebral ischemia-reperfusion injury.
Main Methods:
- Established rat cerebral ischemia/reperfusion (CI/R) and SH-SY5Y cell hypoxia/reoxygenation (H/R) models.
- Measured gene expression, biochemical, and pathophysiological indicators.
- Utilized miR-652 overexpression and agomir treatments in cellular and animal models.
Main Results:
- NOX2 expression increased, while miR-652 levels decreased in both CI/R and H/R models.
- miR-652 overexpression suppressed NOX2, reduced ROS generation, and mitigated cell damage.
- miR-652 agomir treatment decreased NOX2, ROS, and brain tissue injury in CI/R rats.
Conclusions:
- miR-652 directly targets NOX2, offering protection against cerebral ischemia-reperfusion injury.
- miR-652 represents a novel therapeutic target for treating ischemic stroke.

